Home - Products - Others - Other Targets - Hoechst 33342 trihydrochloride

Hoechst 33342 trihydrochloride

CAS No. 875756-97-1

Hoechst 33342 trihydrochloride( bisBenzimide H 33342 trihydrochloride,HOE 33342 trihydrochloride )

Catalog No. M22372 CAS No. 875756-97-1

Hoechst 33342 trihydrochloride is a membrane permeant blue fluorescent DNA stain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 29 In Stock
25MG 44 In Stock
50MG 65 In Stock
100MG 93 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hoechst 33342 trihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Hoechst 33342 trihydrochloride is a membrane permeant blue fluorescent DNA stain.
  • Description
    Hoechst 33342 trihydrochloride is a membrane permeant blue fluorescent DNA stain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    bisBenzimide H 33342 trihydrochloride,HOE 33342 trihydrochloride
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    875756-97-1
  • Formula Weight
    561.93
  • Molecular Formula
    C27H31Cl3N6O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:46 mg/mL (81.86 mM); H2O:5.6 mg/mL (9.97 mM)
  • SMILES
    Cl.Cl.Cl.CCOc1ccc(cc1)-c1nc2ccc(cc2[nH]1)-c1nc2ccc(cc2[nH]1)N1CCN(C)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chazotte B. Labeling nuclear DNA with hoechst 33342. Cold Spring Harb Protoc. 2011 Jan 1;2011(1):pdb.prot5557.
molnova catalog
related products
  • Veratramine

    Veratramine(NSC17821; NSC23880) is useful as a signal transduction inhibitor for treating tumors.

  • Silydianin

    Silydianin exerts inhibition of UGT in human liver. Silydianin exerts inhibition of OATP1B1 OATP1B3 expressed in HEK293 cells. Silydianin exerts inhibition of OATP2B1 expressed in MDCK2 cells.

  • Vazegepant HCl

    Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.